:
The idea that performing a proper succession of imaging tests and techniques allows an accurate and early
diagnosis of cardiac amyloidosis, avoiding the need to perform myocardial biopsy, is becoming increasingly popular.
Furthermore, being imaging techniques non-invasive, it is possible to perform the follow-up of the pathology through
repeated image acquisitions.
In the present review, the various innovative imaging methodologies are presented, and it is discussed how they have been
applied for early diagnosis of cardiac amyloidosis (CA), also to distinguish the two most frequent subtypes in CA:
immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR); this allows to perform the therapy
in a targeted and rapid manner.